Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    No evidence of an additive inhibitory feeding effect following PP and PYY 3-36 administration.

    Neary NM, McGowan BM, Monteiro MP, Jesudason DR, Ghatei MA, Bloom SR.

    Int J Obes (Lond). 2008 Sep;32(9):1438-40. Epub 2008 Jul 8.PMID: 18607381 [PubMed - indexed for MEDLINE]Related articles

    2.

    Low-dose pancreatic polypeptide inhibits food intake in man.

    Jesudason DR, Monteiro MP, McGowan BM, Neary NM, Park AJ, Philippou E, Small CJ, Frost GS, Ghatei MA, Bloom SR.

    Br J Nutr. 2007 Mar;97(3):426-9.PMID: 17313701 [PubMed - indexed for MEDLINE]Related articles

    3.

    A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: a randomised, double-blind, parallel-group, placebo-controlled study in Australian men.

    McMahon CG, Stuckey BG, Lording DW, Wittert GA, Murphy A, Shin J, Sutherland PD, Palmer NR, Lowy MP, Jesudason DR, Fredlund P.

    Int J Clin Pract. 2005 Feb;59(2):143-9.PMID: 15854188 [PubMed - indexed for MEDLINE]Related articles

    4.

    Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.

    Jesudason DR, Dunstan K, Leong D, Wittert GA.

    Diabetes Care. 2003 Feb;26(2):485-90.PMID: 12547886 [PubMed - indexed for MEDLINE]Related articlesFree article